Does Corlanor (ivabradine) cause side effects?
Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker used to treat adults who have chronic heart failure, with symptoms, to reduce their risk of hospitalization for worsening heart failure, and to treat certain children 6 months of age and older who have stable heart failure, with symptoms, that is due to an enlarged heart (dilated cardiomyopathy).
Common side effects of Corlanor include
- increased blood pressure and
- temporary brightness in part of your field of vision.
Serious side effects of Corlanor include
- increased risk of irregular or rapid heartbeat (atrial fibrillation or heart rhythm problems) (symptoms include palpitations, chest pressure, worsened shortness of breath, and near fainting or fainting) or
- slower than normal heart rate (symptoms include dizziness, fatigue, lack of energy; in children poor feeding, difficulty breathing or turning blue).
Drug interactions of Corlanor include grapefruit juice and St. John’s wort because these can affect the way Corlanor works and may cause serious side effects.
Corlanor is primarily metabolized by CYP3A4. Concomitant use of CYP3A4 inhibitors such as azole antifungals, macrolide antibiotics, HIV protease inhibitors, and nefazodone increases Corlanor plasma concentrations and use of CYP3A4 inducers decreases them. Increased plasma concentrations may exacerbate slow heart rate and conduction disturbances.
Avoid concomitant use of CYP3A4 inducers such as St. John’s wort, rifampicin, barbiturates, and phenytoin when using Corlanor.
The risk of slow heart rate increases with concomitant administration of drugs that slow heart rate (e.g., digoxin, amiodarone, beta-blockers). The use of Corlanor is not recommended in patients with demand pacemakers set to rates 60 or more beats per minute.
Corlanor may cause harm to a fetus. Females who are able to get pregnant must use effective birth control during treatment with Corlanor. Tell your doctor right away if you become pregnant during treatment with Corlanor. Breastfeeding is not recommended while using Corlanor.
What are the important side effects of Corlanor (ivabradine)?
Corlanor may cause serious side effects in adults and children, including:
- Increased risk of irregular or rapid heartbeat (atrial fibrillation or heart rhythm problems). Tell your doctor if you feel any of the following symptoms of an irregular or rapid heartbeat:
- heart is pounding or racing (palpitations).
- chest pressure.
- worsened shortness of breath.
- near fainting or fainting.
- Slower than normal heart rate (bradycardia). Tell your doctor if you have:
In young children signs and symptoms of slow heart rate may include:
- poor feeding,
- difficulty breathing or
- turning blue.
The most common side effects of Corlanor are:
- increased blood pressure
- temporary brightness in part of your field of vision. This is usually caused by sudden changes in light (luminous phenomena). This brightness usually happens within the first 2 months of treatment with Corlanor and may go away during or after treatment with Corlanor. Be careful when driving or operating machinery where sudden changes in light can happen, especially when driving at night.
These are not all the side effects of Corlanor. Ask your doctor or pharmacist for more information. Call your doctor for medical advice about side effects.
Corlanor (ivabradine) side effects list for healthcare professionals
Clinically significant adverse reactions that appear in other sections of the labeling include:
- Atrial Fibrillation
- Bradycardia and Conduction Disturbances
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Adult Patients With Heart Failure
In the Systolic Heart failure treatment with the If inhibitor ivabradine Trial (SHIFT), safety was evaluated in 3260 patients treated with Corlanor and 3278 patients given placebo. The median duration of Corlanor exposure was 21.5 months.
The most common adverse drug reactions in the SHIFT trial are shown in Table 2.
Table 2: Adverse Drug Reactions with Rates ≥ 1.0% Higher on Ivabradine than Placebo occurring in > 1% on Ivabradine in SHIFT
N = 3260
N = 3278
|Hypertension, blood pressure increased||8.9%||7.8%|
|Phosphenes, visual brightness||2.8%||0.5%|
Luminous Phenomena (Phosphenes)
- Phosphenes are phenomena described as a transiently enhanced brightness in a limited area of the visual field, halos, image decomposition (stroboscopic or kaleidoscopic effects), colored bright lights, or multiple images (retinal persistency).
- Phosphenes are usually triggered by sudden variations in light intensity. Corlanor can cause phosphenes, thought to be mediated through Corlanor's effects on retinal photoreceptors.
- Onset is generally within the first 2 months of treatment, after which they may occur repeatedly.
- Phosphenes were generally reported to be of mild to moderate intensity and led to treatment discontinuation in < 1% of patients; most resolved during or after treatment.
Pediatric Patients With Heart Failure
- The safety of Corlanor in pediatric patients 6 months to less than 18 years of age is based on a clinical trial in symptomatic heart failure patients with dilated cardiomyopathy and elevated heart rate.
- This trial provides experience in 73 patients treated with Corlanor for a median duration of 397 days, and 42 patients given placebo. Bradycardia (symptomatic and asymptomatic) occurred at rates similar to those in adults. Phosphenes were observed in pediatric patients treated with Corlanor.
Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or establish a causal relationship to drug exposure.
The following adverse reactions have been identified in adults during post-approval use of Corlanor:
- torsade de pointes,
- ventricular fibrillation,
- ventricular tachycardia,
- vertigo, and diplopia, and
- visual impairment.
What drugs interact with Corlanor (ivabradine)?
Cytochrome P450-Based Interactions
Corlanor is primarily metabolized by CYP3A4. Concomitant use of CYP3A4 inhibitors increases ivabradine plasma concentrations and use of CYP3A4 inducers decreases them. Increased plasma concentrations may exacerbate bradycardia and conduction disturbances.
The concomitant use of strong CYP3A4 inhibitors is contraindicated. Examples of strong CYP3A4 inhibitors include
- azole antifungals (e.g., itraconazole),
- macrolide antibiotics (e.g., clarithromycin, telithromycin),
- HIV protease inhibitors (e.g., nelfinavir), and
Avoid concomitant use of moderate CYP3A4 inhibitors when using Corlanor. Examples of moderate CYP3A4 inhibitors include
Avoid concomitant use of CYP3A4 inducers when using Corlanor. Examples of CYP3A4 inducers include
- St. John's wort,
- barbiturates, and
Most patients receiving Corlanor will also be treated with a beta-blocker. The risk of bradycardia increases with concomitant administration of drugs that slow heart rate (e.g., digoxin, amiodarone, beta-blockers). Monitor heart rate in patients taking Corlanor with other negative chronotropes.
Pacemakers In Adults
Corlanor dosing is based on heart rate reduction, targeting a heart rate of 50 to 60 beats per minute in adults. Patients with demand pacemakers set to a rate = 60 beats per minute cannot achieve a target heart rate < 60 beats per minute, and these patients were excluded from clinical trials.
The use of Corlanor is not recommended in patients with demand pacemakers set to rates ≥ 60 beats per minute.
Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker used to treat adults who have chronic heart failure, with symptoms, to reduce their risk of hospitalization for worsening heart failure, and to treat certain children 6 months of age and older who have stable heart failure, with symptoms, that is due to an enlarged heart (dilated cardiomyopathy). Common side effects of Corlanor include increased blood pressure and temporary brightness in part of your field of vision. Corlanor may cause harm to a fetus. Breastfeeding is not recommended while using Corlanor.
Multimedia: Slideshows, Images & Quizzes
How to Lower Your Cholesterol & Save Your Heart
Need to lower your cholesterol levels? Use these smart diet tips to quickly and easily lower your blood cholesterol levels....
Cholesterol Drugs: What to Expect With Heart Medication
When diet and exercise aren't enough, should you turn to drugs? Learn cholesterol basics, drug classes, and available drugs along...
Sudden Cardiac Arrest - Test Your Heart Health IQ
Take the Sudden Cardiac Arrest Quiz. Learning about this potentially deadly condition may save a life.
Heart Failure Quiz
What is heart failure? Learn about this dangerous condition, as well as who is at risk, and what to do about it.
Picture of Heart Detail
The heart is composed of specialized cardiac muscle, and it is four-chambered, with a right atrium and ventricle, and an...
Picture of Heart Catheter
Catheter procedures are much easier than surgery on patients because they involve only a needle puncture in the skin where the...
Picture of Heart
The muscle that pumps blood received from veins into arteries throughout the body. See a picture of the Heart and learn more...
Related Disease Conditions
Congestive Heart Failure (CHF)
Congestive heart failure (CHF) refers to a condition in which the heart loses the ability to function properly. Heart disease, high blood pressure, diabetes, myocarditis, and cardiomyopathies are just a few potential causes of congestive heart failure. Signs and symptoms of congestive heart failure may include fatigue, breathlessness, palpitations, angina, and edema. Physical examination, patient history, blood tests, and imaging tests are used to diagnose congestive heart failure. Treatment of heart failure consists of lifestyle modification and taking medications to decrease fluid in the body and ease the strain on the heart. The prognosis of a patient with congestive heart failure depends on the stage of the heart failure and the overall condition of the individual.
Second Source WebMD Medical Reference
Heart failure (congestive) is caused by many conditions including coronary artery disease, heart attack, cardiomyopathy, and conditions that overwork the heart. Symptoms of heart failure include congested lungs, fluid and water retention, dizziness, fatigue and weakness, and rapid or irregular heartbeats. There are two types of congestive heart failure, systolic or left-sided heart failure; and diastolic or right-sided heart failure. Treatment, prognosis, and life-expectancy for a person with congestive heart failure depends upon the stage of the disease.
What Are the 4 Stages of Congestive Heart Failure?
The New York Heart Association developed the four stages of congestive heart failure depending on the functional capabilities of the heart which includes Class I, Class II, Class III, and Class IV.
What Causes Congestive Heart Failure?
Congestive heart failure is a chronic disease that progresses with time if left untreated. Heart failure can occur due to diseases of the heart, the blood vessels supplying oxygen and nutrients to the heart, or sometimes from factors outside the heart (extracardiac causes). With proper management, people who have congestive heart failure can lead nearly normal lives, depending on the severity of the condition.
Treatment & Diagnosis
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.